These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 14570035)
1. UN steps up action on traditional knowledge. Kapp C Lancet; 2003 Oct; 362(9391):1206. PubMed ID: 14570035 [No Abstract] [Full Text] [Related]
2. New UN agency examines patent protection for traditional knowledge. Kapp C Lancet; 2001 May; 357(9267):1510. PubMed ID: 11377618 [No Abstract] [Full Text] [Related]
4. USA-Morocco deal may extend drug patents to 30 years. Ahmad K Lancet; 2003 Dec; 362(9399):1904. PubMed ID: 14672079 [No Abstract] [Full Text] [Related]
5. Towards revision of the UN drug control conventions: harnessing like-mindedness. Bewley-Taylor DR Int J Drug Policy; 2013 Jan; 24(1):60-8. PubMed ID: 23036654 [TBL] [Abstract][Full Text] [Related]
6. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries. Spectar JM Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914 [No Abstract] [Full Text] [Related]
7. Biotech in post-TRIPS India. Ramani SV; Pradhan P; Ravi M Nat Biotechnol; 2005 Jan; 23(1):18-9. PubMed ID: 15637608 [No Abstract] [Full Text] [Related]
8. Pills, patents, and power: state creation of gray markets as a limit on patent rights. Ghosh S Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138 [No Abstract] [Full Text] [Related]
9. Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals. Correa CM Chic J Int Law; 2002; 3(1):69-85. PubMed ID: 15709300 [No Abstract] [Full Text] [Related]
10. Intellectual property rights and traditional medicine: policy dilemmas at the interface. Timmermans K Soc Sci Med; 2003 Aug; 57(4):745-56. PubMed ID: 12821021 [TBL] [Abstract][Full Text] [Related]
11. Property rights go East. Nature; 2005 Nov; 438(7067):420-1. PubMed ID: 16306959 [No Abstract] [Full Text] [Related]
12. Balancing pills and patents: intellectual property and the HIV/AIDS crisis. Nderitu T E Law; 2001 Sep; 8(3):E5. PubMed ID: 16903022 [No Abstract] [Full Text] [Related]
13. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand. Supakankunti S; Janjaroen WS; Tangphao O; Ratanawijitrasin S; Kraipornsak P; Pradithavanij P Bull World Health Organ; 2001; 79(5):461-70. PubMed ID: 11417042 [TBL] [Abstract][Full Text] [Related]
14. Ending drug registration apartheid: taming data exclusivity and patent/registration linkage. Baker BK Am J Law Med; 2008; 34(2-3):303-44. PubMed ID: 18697696 [No Abstract] [Full Text] [Related]
15. Traditional knowledge and intellectual property. Brody BA Kennedy Inst Ethics J; 2010 Sep; 20(3):231-49. PubMed ID: 21133334 [TBL] [Abstract][Full Text] [Related]
16. Intellectual property protection for plant-related inventions in Europe. Fleck B; Baldock C Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379 [TBL] [Abstract][Full Text] [Related]
17. Intellectual property. Plants and intellectual property: an international appraisal. Koo B; Nottenburg C; Pardey PG Science; 2004 Nov; 306(5700):1295-7. PubMed ID: 15550646 [No Abstract] [Full Text] [Related]
18. Intellectual property and access to ART: unwise choice of terminology. Stallman R PLoS Med; 2006 Nov; 3(11):e509; author reply e510. PubMed ID: 17132062 [No Abstract] [Full Text] [Related]
19. Pharmaceutical patents and some international trade issues: Canada, the United States, and NAFTA. Tancer RS Clin Ther; 1993; 15(6):1177-84; discussion 1120. PubMed ID: 8111813 [TBL] [Abstract][Full Text] [Related]
20. International panel considers global patent system needs reassessment. Ashraf H Lancet; 2002 Sep; 360(9336):858. PubMed ID: 12243929 [No Abstract] [Full Text] [Related] [Next] [New Search]